Blog

Jan 1, 2025, 14:29

Karen Knudsen: President Carter was a staunch supporter of cancer research

Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society, shared a post on LinkedIn:

“President Carter was a staunch supporter of cancer research – and his journey with metastatic melanoma highlights the transformative progress made through cancer discovery.

Diagnosed in 2015 with stage IV melanoma that spread to his brain, President Carter benefitted from groundbreaking immunotherapy. His remarkable response to treatment reflected the significant strides made in tackling this once-devastating disease.

Notably, 14 new therapies for metastatic melanoma have been FDA-approved since 2011, revolutionizing care and dramatically improving outcomes.

A cancer that once carried one of the poorest prognoses now boasts a median survival beyond three years, with some patients achieving long-term remission or even a cure. This progress is proof that investments in science save lives!

Helpful summary on progress and the path forward.”

Karen Knudsen: President Carter was a staunch supporter of cancer research

More posts featuring Karen Knudsen.

Karen E. Knudsen is the Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health.

She also served as president for the Association of American Cancer Institutes (AACI) and on the board of directors of the American Association for Cancer Research (AACR). She serves on the board of advisors for the National Cancer Institute, on 12 external advisory boards for NCI-designated cancer centers and on Exai Bio.

She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.